-
2
-
-
30044438368
-
Intraperitoneal cisplatin and paclitaxel in ovarian cancer
-
Armstrong DK, Bundy B, Wenzel L, et al. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med. 2006;354:34-43.
-
(2006)
N Engl J Med.
, vol.354
, pp. 34-43
-
-
Armstrong, D.K.1
Bundy, B.2
Wenzel, L.3
-
3
-
-
55249120170
-
Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy
-
Wang Z, Smith KS, Murphy M, et al. Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy. Nature. 2008;455:1205-1209.
-
(2008)
Nature.
, vol.455
, pp. 1205-1209
-
-
Wang, Z.1
Smith, K.S.2
Murphy, M.3
-
4
-
-
0028491116
-
Regulation and functions of the glycogen synthase kinase-3 subfamily
-
Woodgett Jr. Regulation and functions of the glycogen synthase kinase-3 subfamily. Semin Cancer Biol. 1994;5:269-275.
-
(1994)
Semin Cancer Biol.
, vol.5
, pp. 269-275
-
-
Woodgett, J.R.1
-
5
-
-
16844374033
-
Glycogen synthase kinase-3beta participates in nuclear factor kappaBYmediated gene transcription and cell survival in pancreatic cancer cells
-
Ougolkov AV, Fernandez-Zapico ME, Savoy DN, et al. Glycogen synthase kinase-3beta participates in nuclear factor kappaBYmediated gene transcription and cell survival in pancreatic cancer cells. Cancer Res. 2005;65:2076-2081.
-
(2005)
Cancer Res.
, vol.65
, pp. 2076-2081
-
-
Ougolkov, A.V.1
Fernandez-Zapico, M.E.2
Savoy, D.N.3
-
6
-
-
53049093524
-
Glycogen synthase kinase-3 inhibition induces glioma cell death through c-MYC, nuclear factor-kappaB, and glucose regulation
-
Kotliarova S, Pastorino S, Kovell LC, et al. Glycogen synthase kinase-3 inhibition induces glioma cell death through c-MYC, nuclear factor-kappaB, and glucose regulation. Cancer Res. 2008;68:6643-6651.
-
(2008)
Cancer Res.
, vol.68
, pp. 6643-6651
-
-
Kotliarova, S.1
Pastorino, S.2
Kovell, L.C.3
-
7
-
-
84857986934
-
Inhibition of glycogen synthase kinase-3 activity triggers an apoptotic response in pancreatic cancer cells through JNK-dependent mechanisms
-
Marchand B, Tremblay I, Cagnol S, et al. Inhibition of glycogen synthase kinase-3 activity triggers an apoptotic response in pancreatic cancer cells through JNK-dependent mechanisms. Carcinogenesis. 2012;33:529-537.
-
(2012)
Carcinogenesis.
, vol.33
, pp. 529-537
-
-
Marchand, B.1
Tremblay, I.2
Cagnol, S.3
-
8
-
-
23044444841
-
Deregulated GSK3beta activity in colorectal cancer: Its association with tumor cell survival and proliferation
-
Shakoori A, Ougolkov A, Yu ZW, et al. Deregulated GSK3beta activity in colorectal cancer: Its association with tumor cell survival and proliferation. Biochem Biophys Res Commun. 2005;334:1365-1373.
-
(2005)
Biochem Biophys Res Commun.
, vol.334
, pp. 1365-1373
-
-
Shakoori, A.1
Ougolkov, A.2
Yu, Z.W.3
-
9
-
-
7644220896
-
Inhibition of glycogen synthase kinase-3 represses androgen receptor activity and prostate cancer cell growth
-
Mazor M, Kawano Y, Zhu H, et al. Inhibition of glycogen synthase kinase-3 represses androgen receptor activity and prostate cancer cell growth. Oncogene. 2004;23:7882-7892.
-
(2004)
Oncogene.
, vol.23
, pp. 7882-7892
-
-
Mazor, M.1
Kawano, Y.2
Zhu, H.3
-
10
-
-
0034805180
-
Lithium inhibits glycogen synthase kinase-3 by competition for magnesium
-
Ryves WJ, Harwood AJ. Lithium inhibits glycogen synthase kinase-3 by competition for magnesium. Biochem Biophys Res Commun. 2001;280:720-725.
-
(2001)
Biochem Biophys Res Commun.
, vol.280
, pp. 720-725
-
-
Ryves, W.J.1
Harwood, A.J.2
-
11
-
-
0029776032
-
A molecular mechanism for the effect of lithium on development
-
Klein PS, Melton DA. A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA. 1996;93: 8455-8459.
-
(1996)
Proc Natl Acad Sci USA.
, vol.93
, pp. 8455-8459
-
-
Klein, P.S.1
Melton, D.A.2
-
12
-
-
33846095134
-
Lithium regulates glycogen synthase kinase-3beta in human peripheral blood mononuclear cells: Implication in the treatment of bipolar disorder
-
Li X, Friedman AB, Zhu W, et al. Lithium regulates glycogen synthase kinase-3beta in human peripheral blood mononuclear cells: Implication in the treatment of bipolar disorder. Biol Psychiatry. 2007;61:216-222.
-
(2007)
Biol Psychiatry.
, vol.61
, pp. 216-222
-
-
Li, X.1
Friedman, A.B.2
Zhu, W.3
-
13
-
-
84857672358
-
Combination of imatinib mesylate with lithium chloride and medroxyprogesterone acetate is highly active in Ishikawa endometrial carcinoma in vitro
-
Bilir A, Erguven M, Ermis E, et al. Combination of imatinib mesylate with lithium chloride and medroxyprogesterone acetate is highly active in Ishikawa endometrial carcinoma in vitro. J Gynecol Oncol. 2011;22:225-232.
-
(2011)
J Gynecol Oncol.
, vol.22
, pp. 225-232
-
-
Bilir, A.1
Erguven, M.2
Ermis, E.3
-
14
-
-
83055191202
-
A potential strategy for high-grade gliomas: Combination treatment with lithium chloride and BmK CT
-
Fu Y, Zheng S, Huang R, et al. A potential strategy for high-grade gliomas: Combination treatment with lithium chloride and BmK CT. Biotechnol Lett. 2012;34:9-17.
-
(2012)
Biotechnol Lett.
, vol.34
, pp. 9-17
-
-
Fu, Y.1
Zheng, S.2
Huang, R.3
-
15
-
-
77954662891
-
Lithium inhibits carcinoid cell growth in vitro
-
Greenblatt DY, Ndiaye M, Chen H, et al. Lithium inhibits carcinoid cell growth in vitro. Am J Transl Res. 2010;2:248-253.
-
(2010)
Am J Transl Res.
, vol.2
, pp. 248-253
-
-
Greenblatt, D.Y.1
Ndiaye, M.2
Chen, H.3
-
16
-
-
79955024465
-
Lithium reduces tumorigenic potential in response to EGF signaling in human colorectal cancer cells
-
Vidal F, de Araujo WM, Cruz ALS, et al. Lithium reduces tumorigenic potential in response to EGF signaling in human colorectal cancer cells. Int J Oncol. 2011;38:1365-1373.
-
(2011)
Int J Oncol.
, vol.38
, pp. 1365-1373
-
-
Vidal, F.1
De Araujo, W.M.2
Cruz, A.L.S.3
-
17
-
-
33746239119
-
Glycogen synthase kinase-3beta positively regulates the proliferation of human ovarian cancer cells
-
Cao Q, Lu X, Feng Y-J. Glycogen synthase kinase-3beta positively regulates the proliferation of human ovarian cancer cells. Cell Res. 2006;16:671-677.
-
(2006)
Cell Res.
, vol.16
, pp. 671-677
-
-
Cao, Q.1
Lu, X.2
Feng, Y.-J.3
-
18
-
-
33750599578
-
Drugs for psychiatric disorders
-
Drugs for psychiatric disorders. Treat Guidel Med Lett. 2006;4:35-46.
-
(2006)
Treat Guidel Med Lett.
, vol.4
, pp. 35-46
-
-
-
19
-
-
33847130464
-
Comparative evaluation of the treatment efficacy of suberoylanilide hydroxamic acid (SAHA) and paclitaxel in ovarian cancer cell lines and primary ovarian cancer cells from patients
-
Sonnemann J, Gange J, Pilz S, et al. Comparative evaluation of the treatment efficacy of suberoylanilide hydroxamic acid (SAHA) and paclitaxel in ovarian cancer cell lines and primary ovarian cancer cells from patients. BMC Cancer. 2006;6:183.
-
(2006)
BMC Cancer
, vol.6
, pp. 183
-
-
Sonnemann, J.1
Gange, J.2
Pilz, S.3
-
20
-
-
79955570598
-
A preclinical and clinical study of lithium in low-grade neuroendocrine tumors
-
Lubner SJ, Kunnimalaiyaan M, Holen KD, et al. A preclinical and clinical study of lithium in low-grade neuroendocrine tumors. Oncologist. 2011;16:452-457.
-
(2011)
Oncologist.
, vol.16
, pp. 452-457
-
-
Lubner, S.J.1
Kunnimalaiyaan, M.2
Holen, K.D.3
|